Syros Pharmaceuticals Inc.

NAS: SYRS

GO
/marketstate/country/us

After Hours

 --Real time quotes

Aug 11, 2022, 4:50 p.m.

/zigman2/quotes/201168308/composite

$

0.91

Change

-0.02 -1.83%

Volume

Volume 5,010

Real time quotes

/zigman2/quotes/201168308/composite

Today's close

$ 0.96

$ 0.93

Change

-0.03 -3.13%

Day low

Day high

$0.86

$0.99

Open

52 week low

52 week high

$0.65

$5.64

Open

Annual Financials for Syros Pharmaceuticals Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue 1.1M2.05M1.98M15.09M23.49M
Cost of Goods Sold (COGS) incl. D&A 1.53M----
COGS excluding D&A -----
Depreciation & Amortization Expense 1.53M1.6M2.72M3.04M3.02M
Depreciation 1.53M1.6M2.72M3.04M3.02M
Amortization of Intangibles -----
Gross Income (426,000)----
20172018201920202021 5-year trend
SG&A Expense 54.26M64.74M77M94.36M119.89M
Research & Development 41.9M50.18M58.25M76.07M97.11M
Other SG&A 12.36M14.56M18.76M18.29M-
Other Operating Expense -----
Unusual Expense ---375,000(16.68M)
EBIT after Unusual Expense ---(82.67M)(82.74M)
Non Operating Income/Expense 676,0002.02M2.3M--
Non-Operating Interest Income ---426,00087,000
Equity in Affiliates (Pretax) -----
Interest Expense ---1.79M3.91M
Gross Interest Expense ---1.79M3.91M
Interest Capitalized -----
Pretax Income (54.01M)(62.28M)(75.44M)(84.04M)(86.56M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (54.01M)(62.28M)(75.44M)(84.04M)(86.56M)
Minority Interest Expense -----
Net Income (54.01M)(62.28M)(75.44M)(84.04M)(86.56M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (54.01M)(62.28M)(75.44M)(84.04M)(86.56M)
Preferred Dividends -----
Net Income Available to Common (54.01M)(62.28M)(75.44M)(84.04M)(86.56M)
EPS (Basic) (2.13)(1.91)(1.88)(1.82)(1.38)
Basic Shares Outstanding 25.41M32.66M40.22M46.05M62.53M
EPS (Diluted) (2.13)(1.91)(1.88)(1.82)(1.38)
Diluted Shares Outstanding 25.41M32.66M40.22M46.05M62.53M
EBITDA (53.16M)(62.69M)(75.02M)(79.26M)(96.4M)
Link to MarketWatch's Slice.